Clincosm LogoSign in Get a demo

Etaliepre-IPP: Inventory of Inappropriate Prescriptions of Proton Pump Inhibitors (PPIs) in People Over 75 Years of Age

Sponsor
University Hospital, Strasbourg, France (Other)
Overall Status
Recruiting
CT.gov ID
NCT05618249
Collaborator
(none)
100
Enrollment
1
Location
36
Anticipated Duration (Months)
2.8
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

This study would have as a starting point the results of a request carried out by the Medical Service Grand Est of the Health Insurance aiming to evaluate the number of boxes of PPI reimbursed in town pharmacy, in patients over 75 years old in the Grand Est of France from 01/01/2018 to 31/12/2018.

It aims to highlight and quantify a possible inappropriate use of PPIs in private practice.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    100 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Retrospective
    Official Title:
    Inventory of Inappropriate Prescriptions of Proton Pump Inhibitors (PPIs) in People Over 75 Years of Age When Taking Over a Patient Base in the SOULTZ Haut-Rhin Sector
    Actual Study Start Date :
    Jan 1, 2020
    Anticipated Primary Completion Date :
    Dec 1, 2022
    Anticipated Study Completion Date :
    Dec 31, 2022

    Outcome Measures

    Primary Outcome Measures

    1. Retrospective systematic analysis of patient prescriptions to identify possible inappropriate use of PPIs in private practice [Files analysed retrospectively from January 01, 2018 to December 31, 2019 will be examined]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    75 Years and Older
    Sexes Eligible for Study:
    All
    Inclusion criteria:

    • Patient over 75 years of age

    • Patient with a PPI in the initial prescription

    • Patient seen at least once between 01/01/2018 and 31/11/2019 in the general practice

    • Patient who has not expressed his opposition, after information, to the reuse of his data for the purpose of this research.

    Exclusion criteria:

    • Patient having expressed his opposition to participate in the study

    • Impossibility to give the patient informed information (difficulties in understanding the subject, ...)

    • Patient under legal protection

    • Patient under guardianship or curatorship

    • Patient who is no longer followed up in the office following an entry into an institution (EHPAD)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Service de Gériatrie - CHU de Strasbourg - France Strasbourg France 67091

    Sponsors and Collaborators

    • University Hospital, Strasbourg, France

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University Hospital, Strasbourg, France
    ClinicalTrials.gov Identifier:
    NCT05618249
    Other Study ID Numbers:
    • 7600
    First Posted:
    Nov 16, 2022
    Last Update Posted:
    Nov 16, 2022
    Last Verified:
    Nov 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by University Hospital, Strasbourg, France
    Peptic Ulcer Disease
    Proton pump inhibitors
    PPI
    Additional relevant MeSH terms:
    Peptic Ulcer

    Study Results

    No Results Posted as of Nov 16, 2022